Skip to main content
. 2022 Aug 16;14(8):e28056. doi: 10.7759/cureus.28056

Table 2. Contrasting results for CD44+/CD24- and prognosis.

This study otherwise showed that CD44+/CD24- had positive prognostic results

Author Year Study population Findings
Kim et al. [32] 2011 A retrospective study. Tissue microarray blocks of 643 cases of invasive breast carcinomas CD44+/CD24- marker was taken as a positive prognostic subgroup in breast neoplasm